Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | FABP3 | P05413 | 7/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.44 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9808856 | 1.00 | FAAH (0.48) | FAAHKDM4ESOAT1MEN1TP53 | |
| SCHEMBL10730060 | 1.00 | FAAH (0.48) | FAAHKDM4ESOAT1MEN1TP53 | |
| SCHEMBL8210289 | 0.92 | ALDH1A1 (0.48) | MEN1KMT2A | |
| SCHEMBL7057715 | 0.92 | ALDH1A1 (0.48) | MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL27383584 | 0.91 | ALDH1A1 (0.47) | MEN1KMT2A | |
| SCHEMBL8208205 | 0.91 | ALDH1A1 (0.46) | MEN1CYP3A4CYP2C19KMT2A | |
| SCHEMBL6841412 | 0.90 | ALDH1A1 (0.58) | FAAHKDM4ESOAT1MEN1CYP3A4 | |
| SCHEMBL29664389 | 0.89 | FAAH (0.47) | FAAHKDM4ESOAT1MEN1TP53 | |
| SCHEMBL29078336 | 0.88 | EPHX2 (0.54) | FAAHKDM4ESOAT1CYP1A2CYP3A4 | |
| SCHEMBL27659885 | 0.86 | ALDH1A1 (0.47) | MEN1CYP3A4CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678626-A1 | LONG-CHAIN ALKENYLOXY-SUBSTITUTED BENZOYL DERIVATIVE AND OLIGONUCLEOTIDE SYNTHESIS METHOD USING SAME | Spera Pharma, Inc. (JP) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024185775-A1 | LONG-CHAIN ALKENYLOXY–SUBSTITUTED BENZOYL DERIVATIVE AND OLIGONUCLEOTIDE SYNTHESIS METHOD USING SAME | スペラファーマ株式会社 | 2024-09-12 | — | — | WO | disclosed |
| US-20240294462-A1 | Method for the Synthesis of Ionizable Lipids Using a Doubly Alkylated Intermediate | NANOVATION THERAPEUTICS INC. (CA) | 2024-09-05 | — | — | US | disclosed |
| EP-3721943-A1 | LIPIDS, LIPID COMPOSITIONS AND METHODS OF USING THEM | Novartis AG (CH) | 2020-10-14 | — | — | EP | disclosed |
| US-9301923-B2 | Lipids, lipid compositions, and methods of using them | NOVARTIS AG (CH) | 2016-04-05 | — | — | US | disclosed |
| US-20140309277-A1 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | NOVARTIS AG (CH) | 2014-10-16 | — | — | US | disclosed |
| US-8748358-B2 | Lubricating oil additive, lubricating oil composition containing the same, various low-friction sliding members, rolling bearing, and sliding bearing | IDEMITSU KOSAN CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| EP-2516010-A2 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | Novartis AG (CH) | 2012-10-31 | — | — | EP | disclosed |
| US-20110200582-A1 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | NOVARTIS AG (CH) | 2011-08-18 | — | — | US | disclosed |
| WO-2011076807-A2 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | NOVARTIS AG (CH) | 2011-06-30 | — | — | WO | disclosed |
| EP-0187702-B1 | N-(OMEGA,OMEGA-1-DIALKOXY)- AND N-(OMEGA,OMEGA-1-DIALKENOXY)-ALK-1-YL-N,N,N-TRISUBSTITUTED AMMONIUM SURFACTANTS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | SYNTEX (U.S.A.) INC. (US) | 1990-03-14 | — | — | EP | disclosed |
| US-4897355-A | LIPISOME-POLYANION COMPLEX | SYNTEX (U.S.A.) INC. (US) | 1990-01-30 | — | — | US | disclosed |
| US-4654348-A | Pyrazolo[4,3-d]pyrimidine derivative, process for its production, antihyperlipidemic agent containing it, its intermediate, and process for the production of the intermediate | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-03-31 | — | — | US | disclosed |
| EP-0188311-A2 | Pharmaceutical formulation of nicardipine and 1,2-dioxy-omega-trialkylammonium compounds | SYNTEX (U.S.A.) INC. (US) | 1986-07-23 | — | — | EP | disclosed |
| EP-0187702-A1 | N-(omega,omega-1-dialkoxy)- and N-(omega,omega-1-dialkenoxy)-alk-1-yl-N,N,N-trisubstituted ammonium surfactants, their preparation and pharmaceutical formulations containing them | SYNTEX (U.S.A.) INC. (US) | 1986-07-16 | — | — | EP | disclosed |
| EP-0172007-A2 | Stable liposomes with aqueous-soluble medicaments and methods for their preparation | SYNTEX (U.S.A.) INC. (US) | 1986-02-19 | — | — | EP | disclosed |
| EP-0157415-A2 | Pyrazolo[4,3-d] pyrimidine derivative process for its production antihyperlipidemic agent containing it, its intermediate, and process for the production of the intermediate | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1985-10-09 | — | — | EP | disclosed |
| US-4410509-A | NONHYDROCARBON 9-TRICOSENE DERIVATIVES | TRUSTEES OF DAVIDSON COLLEGE (US) | 1983-10-18 | — | — | US | disclosed |
| US-4249029-A | REACTING ALKYL OR ALKENYL SULFONATE WITH COPPER OR CUPROLITHIUM ORGANIC COMPOUND | AIRWICK INDUSTRIES, INC. (US) | 1981-02-03 | — | — | US | disclosed |
| US-4028422-A | SEX ATTRACTANTS FOR FLIES | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110200582-A1 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | SGMS1, SGMS2, LIPC | FAAH 1342/4885KDM4E 4419/4885SOAT1 315/4885 |
| US-20140309277-A1 | LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM | SGMS1, SGMS2, LIPC | FAAH 1342/4885KDM4E 4419/4885SOAT1 315/4885 |
| US-20240294462-A1 | Method for the Synthesis of Ionizable Lipids Using a Doubly Alkylated Intermediate | SGMS1, SGMS2, LIPC | FAAH 413/4885KDM4E 2859/4885SOAT1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.